CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease.
Sara PicóAlberto ParrasMaría Santos-GalindoJulia Pose-UtrillaMargarita CastroEnrique FragaIvó H HernándezAinara ElorzaHéctor AntaNan WangLaura Martí-SánchezEulàlia BellocPaula Garcia-EsparciaJuan José GarridoIsidro FerrerDaniel Macías-GarcíaPablo MirRafael ArtuchBelén PérezFélix HernándezPilar NavarroJosé Luis López-Sendon MorenoTeresa IglesiasX William YangRaúl MéndezJosé J LucasPublished in: Science translational medicine (2021)
[Figure: see text].